Electromed Non Operating Income Net Other from 2010 to 2024
| ELMD Stock | USD 31.06 0.57 1.87% |
Non Operating Income Net Other | First Reported 2010-12-31 | Previous Quarter -10.8 K | Current Value -11.3 K | Quarterly Volatility 342.77856242 |
Check Electromed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Electromed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 684.7 K, Interest Expense of 85.2 K or Selling General Administrative of 18.5 M, as well as many indicators such as Price To Sales Ratio of 1.38, Dividend Yield of 0.0 or PTB Ratio of 2.65. Electromed financial statements analysis is a perfect complement when working with Electromed Valuation or Volatility modules.
Electromed | Non Operating Income Net Other |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Electromed is a strong investment it is important to analyze Electromed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Electromed's future performance. For an informed investment choice regarding Electromed Stock, refer to the following important reports:Check out the analysis of Electromed Correlation against competitors. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.809 | Earnings Share 0.72 | Revenue Per Share 6.39 | Quarterly Revenue Growth 0.09 | Return On Assets 0.0839 |
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.